Page last updated: 2024-10-30
mesalamine and Mediastinal Neoplasms
mesalamine has been researched along with Mediastinal Neoplasms in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Mediastinal Neoplasms: Tumors or cancer of the MEDIASTINUM.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
López-Iñiguez, A | 1 |
Pérez-Gutiérrez, MT | 1 |
Lambraño-Castillo, D | 1 |
Sierra-Madero, JG | 1 |
Other Studies
1 other study available for mesalamine and Mediastinal Neoplasms
Article | Year |
---|---|
Necrotic lesion in an immunosuppressed patient.
Topics: Aged; Colitis, Ulcerative; Ecthyma; Fatal Outcome; Gangrene; Humans; Immunocompromised Host; Immunos | 2018 |